Comparison of oral melphalan, CCNU, and BCNU with and without vincristine and prednisone in the treatment of multiple myeloma. Cancer and Leukemia Group B experience.
about
The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study.Hematopoietic Cell Transplantation for Multiple Myeloma.Objective evaluation of the role of vincristine in induction and maintenance therapy for myelomatosis. Medical Research Council Working Party on Leukaemia in Adults.Impact of early response to sequential high-dose chemotherapy on outcome of patients with advanced myeloma and poor prognostic features.Myeloma (multiple).
P2860
Comparison of oral melphalan, CCNU, and BCNU with and without vincristine and prednisone in the treatment of multiple myeloma. Cancer and Leukemia Group B experience.
description
1982 nî lūn-bûn
@nan
1982 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1982 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
name
Comparison of oral melphalan, ...... d Leukemia Group B experience.
@ast
Comparison of oral melphalan, ...... d Leukemia Group B experience.
@en
type
label
Comparison of oral melphalan, ...... d Leukemia Group B experience.
@ast
Comparison of oral melphalan, ...... d Leukemia Group B experience.
@en
prefLabel
Comparison of oral melphalan, ...... d Leukemia Group B experience.
@ast
Comparison of oral melphalan, ...... d Leukemia Group B experience.
@en
P2093
P1433
P1476
Comparison of oral melphalan, ...... d Leukemia Group B experience.
@en
P2093
Cornwell GG 3rd
Glowienka LP
Haurani FI
Henderson E
McIntyre OR
P304
P356
10.1002/1097-0142(19821101)50:9<1669::AID-CNCR2820500902>3.0.CO;2-N
P407
P577
1982-11-01T00:00:00Z